ONGLYZA 5 mg, comprimé pelliculé — 30 plaquette(s) thermoformée(s) aluminium de 1 comprimé(s) pré-découpées unidoses.
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400939735887 -
CIP7
3973588 -
CIS
66862731 -
Registration number
EU/1/09/545
What the source publishes
- Holder
- ASTRAZENECA AB
- Active ingredients
- SAXAGLIPTINE, CHLORHYDRATE DE SAXAGLIPTINE
- Form
- comprimé pelliculé
- Package
- 30 plaquette(s) thermoformée(s) aluminium de 1 comprimé(s) pré-découpées unidoses.
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2009-10-01
- Prescription
- Prescription or restricted
Names this record is found by
- ONGLYZA 5 mg, comprimé pelliculé — 30 plaquette(s) thermoformée(s) aluminium de 1 comprimé(s) pré-découpées unidoses.
- ONGLYZA 5 mg, comprimé pelliculé
- SAXAGLIPTINE
- CHLORHYDRATE DE SAXAGLIPTINE
Complete source data
{
"cis": "66862731",
"cip7": "3973588",
"form": "comprimé pelliculé",
"name": "ONGLYZA 5 mg, comprimé pelliculé — 30 plaquette(s) thermoformée(s) aluminium de 1 comprimé(s) pré-découpées unidoses.",
"cip13": "3400939735887",
"holder": "ASTRAZENECA AB",
"routes": [
"orale"
],
"holders": [
"ASTRAZENECA AB"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "15.04",
"authorisedOn": "2009-10-01",
"compositions": [
{
"name": "SAXAGLIPTINE",
"nature": "FT",
"strength": "5 mg",
"linkageNumber": "1",
"substanceCode": "27375",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
},
{
"name": "CHLORHYDRATE DE SAXAGLIPTINE",
"nature": "SA",
"strength": null,
"linkageNumber": "1",
"substanceCode": "45154",
"dosageReference": null,
"pharmaceuticalElement": "comprimé"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "liste I",
"dispensingFee": "1.02",
"medicinePrice": "14.02",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "ONGLYZA 5 mg, comprimé pelliculé",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "30 plaquette(s) thermoformée(s) aluminium de 1 comprimé(s) pré-découpées unidoses.",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"15 %"
],
"marketingDeclaredOn": "2010-09-03",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"SAXAGLIPTINE",
"CHLORHYDRATE DE SAXAGLIPTINE"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"liste I"
],
"reimbursementIndications": "Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Amélioration du contrôle de la glycémie en cas de diabète de type 2 (adultes à partir de 18 ans), lorsque ce médicament est utilisé :<br>. en monothérapie,<br>. en bithérapie orale, en association à la metformine ou un sulfamide hypoglycémiant ou une thiazolidinedione,<br>. en trithérapie orale, en association à l¿insuline et à la metformine ou à la metformine et à un sulfamide hypoglycémiant. ; JOURNAL OFFICIEL ; 24/07/15",
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/09/545",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400939735887"